https://www.mlo-online.com/disease/cancer/news/55381402/does-glp-1-impact-breast-cancer-riskMLO Onlineen2026-06-02T14:34:38.000ZDoes GLP-1 impact breast cancer risk?https://www.mlo-online.com/management/news/55381397/diazyme-laboratories-announces-acquisition-of-carolina-liquid-chemistriesMLO Onlineen2026-06-02T14:24:56.000ZDiazyme Laboratories announces acquisition of Carolina Liquid Chemistrieshttps://www.mlo-online.com/disease/news/55381392/possible-new-opioid-use-disorder-treatment-incomingMLO Onlineen2026-06-02T14:15:44.000ZPossible new opioid use disorder treatment incoming https://www.mlo-online.com/molecular/precision-medicine/news/55381385/leica-biosystems-astrazeneca-and-daiichi-sankyo-expand-collaboration-to-enhance-precision-medicineMLO Onlineen2026-06-02T14:09:36.000ZLeica Biosystems, AstraZeneca, and Daiichi Sankyo expand collaboration to enhance precision medicinehttps://www.mlo-online.com/management/news/55381099/hhs-announces-final-rule-to-enhance-federal-independent-dispute-resolutionMLO Onlineen2026-06-01T15:46:38.000ZHHS announces final rule to enhance Federal Independent Dispute Resolutionhttps://www.mlo-online.com/disease/news/55381097/hhs-to-address-lyme-diseaseMLO Onlineen2026-06-01T15:46:02.000ZHHS to address Lyme diseasehttps://www.mlo-online.com/molecular/news/55381095/thermo-fisher-scientific-unveils-new-product-for-routine-nucleic-acid-verificationMLO Onlineen2026-06-01T15:37:44.000ZThermo Fisher Scientific unveils new product for routine nucleic acid verificationhttps://www.mlo-online.com/diagnostics/assays/news/55381088/qiagen-announces-custom-digital-pcr-assays-for-bundibugyo-ebolavirus-researchMLO Onlineen2026-06-01T15:15:57.000ZQIAGEN announces custom digital PCR assays for Bundibugyo ebolavirus research